Moreover several other studies have shown that high levels of WEE1 expression are associated with worse prognostic factors, including metastasis, increased proliferative biomarkers, and resistance to treatment, in other cancers including glioblastoma, glioma, gastric cancer, and malignant melanoma [20,62,63,64]. The gene discussed is WEE1; the disease is cancer.